TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production

Finlay W. McNab, John Ewbank, Ricardo Rajsbaum, Evangelos Stavropoulos, Anna Martirosyan, Paul S. Redford, Xuemei Wu, Christine M. Graham, Margarida Saraiva, Philip Tsichlis, Damien J. Chaussabel, Steven C. Ley, Anne O'Garra

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading cause of mortality and morbidity worldwide, causing ~1.4 million deaths per year. Key immune components for host protection during tuberculosis include the cytokines IL-12, IL-1, and TNF-α, as well as IFN-γ and CD4+ Th1 cells. However, immune factors determining whether individuals control infection or progress to active tuberculosis are incompletely understood. Excess amounts of type I IFN have been linked to exacerbated disease during tuberculosis in mouse models and to active disease in patients, suggesting tight regulation of this family of cytokines is critical to host resistance. In addition, the immunosuppressive cytokine IL-10 is known to inhibit the immune response to M. tuberculosis in murine models through the negative regulation of key proinflammatory cytokines and the subsequent Th1 response. We show in this study, using a combination of transcriptomic analysis, genetics, and pharmacological inhibitors, that the TPL-2-ERK1/2 signaling pathway is important in mediating host resistance to tuberculosis through negative regulation of type I IFN production. The TPL-2-ERK1/2 signaling pathway regulated production by macrophages of several cytokines important in the immune response to M. tuberculosis as well as regulating induction of a large number of additional genes, many in a type I IFN-dependent manner. In the absence of TPL-2 in vivo, excess type I IFN promoted IL-10 production and exacerbated disease. These findings describe an important regulatory mechanism for controlling tuberculosis and reveal mechanisms by which type I IFN may promote susceptibility to this important disease.

Original languageEnglish
Pages (from-to)1732-1743
Number of pages12
JournalJournal of Immunology
Volume191
Issue number4
DOIs
Publication statusPublished - 15 Aug 2013
Externally publishedYes

Fingerprint

Bacterial Infections
Tuberculosis
Cytokines
Mycobacterium tuberculosis
MAP Kinase Signaling System
Interleukin-10
Th1 Cells
Immunologic Factors
Interleukin-12
Immunosuppressive Agents
Infection Control
Interleukin-1
Macrophages
Pharmacology
Morbidity
Mortality
Genes

ASJC Scopus subject areas

  • Immunology

Cite this

McNab, F. W., Ewbank, J., Rajsbaum, R., Stavropoulos, E., Martirosyan, A., Redford, P. S., ... O'Garra, A. (2013). TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. Journal of Immunology, 191(4), 1732-1743. https://doi.org/10.4049/jimmunol.1300146

TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. / McNab, Finlay W.; Ewbank, John; Rajsbaum, Ricardo; Stavropoulos, Evangelos; Martirosyan, Anna; Redford, Paul S.; Wu, Xuemei; Graham, Christine M.; Saraiva, Margarida; Tsichlis, Philip; Chaussabel, Damien J.; Ley, Steven C.; O'Garra, Anne.

In: Journal of Immunology, Vol. 191, No. 4, 15.08.2013, p. 1732-1743.

Research output: Contribution to journalArticle

McNab, FW, Ewbank, J, Rajsbaum, R, Stavropoulos, E, Martirosyan, A, Redford, PS, Wu, X, Graham, CM, Saraiva, M, Tsichlis, P, Chaussabel, DJ, Ley, SC & O'Garra, A 2013, 'TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production', Journal of Immunology, vol. 191, no. 4, pp. 1732-1743. https://doi.org/10.4049/jimmunol.1300146
McNab, Finlay W. ; Ewbank, John ; Rajsbaum, Ricardo ; Stavropoulos, Evangelos ; Martirosyan, Anna ; Redford, Paul S. ; Wu, Xuemei ; Graham, Christine M. ; Saraiva, Margarida ; Tsichlis, Philip ; Chaussabel, Damien J. ; Ley, Steven C. ; O'Garra, Anne. / TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. In: Journal of Immunology. 2013 ; Vol. 191, No. 4. pp. 1732-1743.
@article{9dca962c7bd3444b8f5322c3928cc5b4,
title = "TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production",
abstract = "Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading cause of mortality and morbidity worldwide, causing ~1.4 million deaths per year. Key immune components for host protection during tuberculosis include the cytokines IL-12, IL-1, and TNF-α, as well as IFN-γ and CD4+ Th1 cells. However, immune factors determining whether individuals control infection or progress to active tuberculosis are incompletely understood. Excess amounts of type I IFN have been linked to exacerbated disease during tuberculosis in mouse models and to active disease in patients, suggesting tight regulation of this family of cytokines is critical to host resistance. In addition, the immunosuppressive cytokine IL-10 is known to inhibit the immune response to M. tuberculosis in murine models through the negative regulation of key proinflammatory cytokines and the subsequent Th1 response. We show in this study, using a combination of transcriptomic analysis, genetics, and pharmacological inhibitors, that the TPL-2-ERK1/2 signaling pathway is important in mediating host resistance to tuberculosis through negative regulation of type I IFN production. The TPL-2-ERK1/2 signaling pathway regulated production by macrophages of several cytokines important in the immune response to M. tuberculosis as well as regulating induction of a large number of additional genes, many in a type I IFN-dependent manner. In the absence of TPL-2 in vivo, excess type I IFN promoted IL-10 production and exacerbated disease. These findings describe an important regulatory mechanism for controlling tuberculosis and reveal mechanisms by which type I IFN may promote susceptibility to this important disease.",
author = "McNab, {Finlay W.} and John Ewbank and Ricardo Rajsbaum and Evangelos Stavropoulos and Anna Martirosyan and Redford, {Paul S.} and Xuemei Wu and Graham, {Christine M.} and Margarida Saraiva and Philip Tsichlis and Chaussabel, {Damien J.} and Ley, {Steven C.} and Anne O'Garra",
year = "2013",
month = "8",
day = "15",
doi = "10.4049/jimmunol.1300146",
language = "English",
volume = "191",
pages = "1732--1743",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production

AU - McNab, Finlay W.

AU - Ewbank, John

AU - Rajsbaum, Ricardo

AU - Stavropoulos, Evangelos

AU - Martirosyan, Anna

AU - Redford, Paul S.

AU - Wu, Xuemei

AU - Graham, Christine M.

AU - Saraiva, Margarida

AU - Tsichlis, Philip

AU - Chaussabel, Damien J.

AU - Ley, Steven C.

AU - O'Garra, Anne

PY - 2013/8/15

Y1 - 2013/8/15

N2 - Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading cause of mortality and morbidity worldwide, causing ~1.4 million deaths per year. Key immune components for host protection during tuberculosis include the cytokines IL-12, IL-1, and TNF-α, as well as IFN-γ and CD4+ Th1 cells. However, immune factors determining whether individuals control infection or progress to active tuberculosis are incompletely understood. Excess amounts of type I IFN have been linked to exacerbated disease during tuberculosis in mouse models and to active disease in patients, suggesting tight regulation of this family of cytokines is critical to host resistance. In addition, the immunosuppressive cytokine IL-10 is known to inhibit the immune response to M. tuberculosis in murine models through the negative regulation of key proinflammatory cytokines and the subsequent Th1 response. We show in this study, using a combination of transcriptomic analysis, genetics, and pharmacological inhibitors, that the TPL-2-ERK1/2 signaling pathway is important in mediating host resistance to tuberculosis through negative regulation of type I IFN production. The TPL-2-ERK1/2 signaling pathway regulated production by macrophages of several cytokines important in the immune response to M. tuberculosis as well as regulating induction of a large number of additional genes, many in a type I IFN-dependent manner. In the absence of TPL-2 in vivo, excess type I IFN promoted IL-10 production and exacerbated disease. These findings describe an important regulatory mechanism for controlling tuberculosis and reveal mechanisms by which type I IFN may promote susceptibility to this important disease.

AB - Tuberculosis, caused by Mycobacterium tuberculosis, remains a leading cause of mortality and morbidity worldwide, causing ~1.4 million deaths per year. Key immune components for host protection during tuberculosis include the cytokines IL-12, IL-1, and TNF-α, as well as IFN-γ and CD4+ Th1 cells. However, immune factors determining whether individuals control infection or progress to active tuberculosis are incompletely understood. Excess amounts of type I IFN have been linked to exacerbated disease during tuberculosis in mouse models and to active disease in patients, suggesting tight regulation of this family of cytokines is critical to host resistance. In addition, the immunosuppressive cytokine IL-10 is known to inhibit the immune response to M. tuberculosis in murine models through the negative regulation of key proinflammatory cytokines and the subsequent Th1 response. We show in this study, using a combination of transcriptomic analysis, genetics, and pharmacological inhibitors, that the TPL-2-ERK1/2 signaling pathway is important in mediating host resistance to tuberculosis through negative regulation of type I IFN production. The TPL-2-ERK1/2 signaling pathway regulated production by macrophages of several cytokines important in the immune response to M. tuberculosis as well as regulating induction of a large number of additional genes, many in a type I IFN-dependent manner. In the absence of TPL-2 in vivo, excess type I IFN promoted IL-10 production and exacerbated disease. These findings describe an important regulatory mechanism for controlling tuberculosis and reveal mechanisms by which type I IFN may promote susceptibility to this important disease.

UR - http://www.scopus.com/inward/record.url?scp=84881454396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881454396&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1300146

DO - 10.4049/jimmunol.1300146

M3 - Article

VL - 191

SP - 1732

EP - 1743

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -